Scientists discover how pancreatic cancer rewrites its DNA to escape treatment

Researchers at NYU Langone Health have identified how pancreatic cancer cells reorganize their DNA to become more aggressive and resistant to treatment. By analyzing individual tumor cells, the team discovered that distinct cell populations, or clones, evolve to survive therapy and spread throughout the body.
Why it matters
Mapping the genetic evolution of pancreatic cancer provides a roadmap for developing more effective, targeted therapies for one of the deadliest forms of cancer.
Scientists have uncovered new details about how pancreatic cancer constantly changes its genetic makeup, allowing it to become more aggressive, spread throughout the body, and resist treatment. By examining nearly half a million individual cancer cells, researchers identified genetic changes that could reveal new ways to fight one of the deadliest forms of cancer.
The study, conducted by scientists at NYU Langone Health and its Perlmutter Cancer Center, focused on pancreatic ductal adenocarcinoma, a particularly difficult cancer to treat. Nearly 85 percent of patients die within five years of being diagnosed.
Although researchers have already linked more than half a dozen genes to the disease, much remains unknown about how pancreatic cancer develops and adapts. By examining tumor cells individually rather than studying them in large groups, the team gained a clearer understanding of how different populations of cancer cells change their DNA as the disease progresses.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in